Advisor Group’s CASI Pharmaceuticals CASI Stock Holding History

Advisor Group’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Buy	+1	New	+$32	﹤0.01%	5313
2019 Q1	–	Sell	-9	Closed	–	–	5218
2018 Q4	$0	Hold	9	–	–	﹤0.01%	5109
2018 Q3	$0	Hold	9	–	–	﹤0.01%	5108
2018 Q2	$1K	Hold	9	–	–	﹤0.01%	4777
2018 Q1	$0	Hold	9	–	–	﹤0.01%	4954
2017 Q4	$0	Hold	9	–	–	﹤0.01%	4962
2017 Q3	$0	Hold	9	–	–	﹤0.01%	4842
2017 Q2	$0	Sell	9 -4	-31%	-$43	﹤0.01%	4791
2017 Q1	$0	Hold	13	–	–	﹤0.01%	4689
2016 Q4	$0	Hold	13	–	–	﹤0.01%	4508
2016 Q3	$0	Hold	13	–	–	﹤0.01%	4477
2016 Q2	$0	Buy	+13	New	+$164	﹤0.01%	4401

Other funds holding CASI

IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return

Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return